Vivos (RDGL) Return on Capital Employed Growth (1y) (2012 - 2025)
Vivos (RDGL) Return on Capital Employed Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 125.00 |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | -361.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -361.00 |
| Sep 30, 2025 | 8,514.00 |
| Jun 30, 2025 | 9,025.00 |
| Mar 31, 2025 | 11,064.00 |
| Dec 31, 2024 | 5,034.00 |
| Sep 30, 2024 | -3,515.00 |
| Jun 30, 2024 | -5,187.00 |
| Mar 31, 2024 | -8,967.00 |
| Dec 31, 2023 | -6,904.00 |
| Sep 30, 2023 | -1,935.00 |
| Jun 30, 2023 | 5,439.00 |
| Mar 31, 2023 | 8,758.00 |
| Dec 31, 2022 | 1,073.00 |
| Sep 30, 2022 | 2,639.00 |
| Jun 30, 2022 | -5,415.00 |
| Mar 31, 2022 | -14,192.00 |
| Dec 31, 2021 | -31,454.00 |
| Sep 30, 2021 | -26,342.00 |
| Dec 31, 2020 | 7,013.00 |
| Sep 30, 2020 | -12,170.00 |